Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD,MPH,PhD, John P Galvin, MDMS,MPH, Damiano Rondelli, MD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 3081.

https://doi.org/10.1182/blood-2019-131914

Published: 2019

Journal Articles

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

Hongyu Zhang, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Qi Chen, PhD, Yuanzhen Cao, Kevin Pinz, Fang Liu, MD PhD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD

Blood (2019) 134 (Supplement_1): 2881.

https://doi.org/10.1182/blood-2019-122789

Published: 2019

Journal Articles

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Elisabetta Xue, MD, Hu Xie, Wendy Leisenring, ScD, Louise E Kimball, PhD RN, Sonia Goyal, Lisa Chung, Rachel Blazevic, Byron Maltez, Ann Dahlberg, MD, Rachel B. Salit, MD, Colleen Delaney, MD MSc, Steven A. Pergam, MDMPH, Michael Boeckh, MD, Filippo Milano, MD PhD, Joshua Aiden Hill, MD

Blood (2019) 134 (Supplement_1): 4556.

https://doi.org/10.1182/blood-2019-124211

Published: 2019

Journal Articles

A National, Multicenter, Non-Interventional Study of Pomalidomide in Relapsed/Refractory Multiple Myeloma: Updated Results from the Miroir Study

Blood (2018) 132 (Supplement 1): 3238.

https://doi.org/10.1182/blood-2018-99-111892

Published: 2018

Journal Articles

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

David Simpson, MBChB, FRACP, FRCPA, Henry Chan, MBChB

Blood (2018) 132 (Supplement 1): 3306.

https://doi.org/10.1182/blood-2018-99-110891

Published: 2018

Journal Articles

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Alfaraj Abeer, MBBS, Daniel R Reed, MD, Gina Petroni, PhD, Sandra Monson, PhD, Paige Williams, Kathlene DeGregory, PharmD, BCOP, Leonid Volodin, MD, Tamila L Kindwall-Keller, DO, Karen K. Ballen, MD

Blood (2018) 132 (Supplement 1): 5708.

https://doi.org/10.1182/blood-2018-99-117068

Published: 2018

Journal Articles

Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients

Prashant Sharma, MD, Jennifer MacDonald, Jeff Kaiser, Jennifer Tobin, Matthew Miller, Maheen Abidi, MD, Esther Benamu, MD, Enkhtsetseg Purev, MD PhD, Bradley M. Haverkos, MD MPH, MS, Jonathan A Gutman, MD

Blood (2018) 132 (Supplement 1): 4659.

https://doi.org/10.1182/blood-2018-99-110211

Published: 2018

Journal Articles

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Qi Wei, Yongqiang Wei, MD, Ru Feng, MD, Xiaolei Wei

Blood (2018) 132 (Supplement 1): 5655.

https://doi.org/10.1182/blood-2018-99-113369

Published: 2018

Journal Articles

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Anum Qureshi, Muhammad Junaid Tariq, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Shehroz Aslam, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ahmad Kamal, MD, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2018-99-110748

Published: 2018

Journal Articles

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Smith Giri, MBBS, Weiwei Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD MS, Scott F Huntington, MDMPH

Blood (2018) 132 (Supplement 1): 978.

https://doi.org/10.1182/blood-2018-99-119791

Published: 2018

Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Claudia A.M. Stege, MD, Kazem Nasserinejad, PhD, Mark-David Levin, MDPhD, Noortje Thielen, MD PhD, Saskia K. Klein, MD PhD, Inge Ludwig, MD MSc, Matthijs Westerman, MD, Paula F Ypma, MDPhD, Yavuz Bilgin, MDPhD, Maaike Sohne, MD, Esther de Waal, PhD, Niels WCJ van de Donk, MD PhD, Pieter Sonneveld, MDPhD, Sonja Zweegman, MDPhD

Blood (2018) 132 (Supplement 1): 596.

https://doi.org/10.1182/blood-2018-99-114668

Published: 2018

Journal Articles

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kahee A. Mohammed, MD MPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 2174.

https://doi.org/10.1182/blood.V130.Suppl_1.2174.2174

Published: 2017

Journal Articles

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Jacqueline Chu, BA, Syed Basir Hussaini, BS, Nidhi Sharma, PhD, Nita Williams, BS, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 4645.

https://doi.org/10.1182/blood.V130.Suppl_1.4645.4645

Published: 2017

Journal Articles

Use of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors

Siyang Leng, MD, Suzanne Lentzsch, MD PhD, Yanhan Shen, MS, Jason D Wright, MD MS, Dawn Hershman, MD MS, Alfred I Neugut, MD PhD

Blood (2017) 130 (Supplement 1): 2117.

https://doi.org/10.1182/blood.V130.Suppl_1.2117.2117

Published: 2017

Journal Articles

Patient Characteristics, Treatment Patterns and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients in Japan

Gyungjin Jun, MS, Katarina Luptakova, Hiroo Koizumi, Kosuke Iwasaki, F.I.A.J., M.A.A.A., M.B.A., Shinzo Hiroi, Junpei Soeda, MD PhD

Blood (2016) 128 (22): 5950.

https://doi.org/10.1182/blood.V128.22.5950.5950

Published: 2016

Journal Articles

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Joshua M. Allen, MD, Lisa A. Rybicki, MS, Paolo F. Caimi, MD, Deepa Jagadeesh, MD MPH, Robert M. Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Matt Kalaycio, MD, Brian T. Hill, MD PhD

Blood (2015) 126 (23): 4167.

https://doi.org/10.1182/blood.V126.23.4167.4167

Published: 2015

Journal Articles

Superiority of Outcome for Patients with Late-Onset EBV Viremia Post Allogeneic Stem Cell Transplantation: A Chinese Multicenter Survey

Jia Chen, Feng Chen, Yang Xu, Ying Wang, Ziling Zhu, Jing Xu, Xiaoli Li, Chunmei Ye, Xiebing Bao, Aining Sun, PhD, Wu Depei, MD

Blood (2015) 126 (23): 5443.

https://doi.org/10.1182/blood.V126.23.5443.5443

Published: 2015

Journal Articles

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Kareem Jamani, MD, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 1963.

https://doi.org/10.1182/blood.V126.23.1963.1963

Published: 2015

Journal Articles

Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG)

Natali Pflug, MD, Georg Hopfinger, MD, Paula Cramer, MD, Alexandra Schrader, PhD, Nicole Weit, PhD, Rita Meister, Miriam Thiel, Tanja Annolleck, Anne Westermann, Till M Seiler, MD, Thorsten Zenz, MD, Jan Duerig, MD, Jasmin Bahlo, Karl-Anton Kreuzer, MD, Stephan Stilgenbauer, MD, Anna-Maria Fink, MD, Barbara Eichhorst, MD, Michael Hallek, MD, Marco Herling, MD

Blood (2014) 124 (21): 1999.

https://doi.org/10.1182/blood.V124.21.1999.1999

Published: 2014

Journal Articles

Prognostic Factors of Infections and Effect of Primary Anti-Infectious Prophylaxis in MDS Patients Treated with Azacitidine (AZA): A Prospective Study

Marie Sebert, Claire Aguilar, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Olivier Lortholary, MD PhD, Pierre Fenaux

Blood (2014) 124 (21): 1917.

https://doi.org/10.1182/blood.V124.21.1917.1917

Published: 2014

NARROW

High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

A National, Multicenter, Non-Interventional Study of Pomalidomide in Relapsed/Refractory Multiple Myeloma: Updated Results from the Miroir Study

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Use of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors

Patient Characteristics, Treatment Patterns and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients in Japan

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Superiority of Outcome for Patients with Late-Onset EBV Viremia Post Allogeneic Stem Cell Transplantation: A Chinese Multicenter Survey

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Prognostic Factors of Infections and Effect of Primary Anti-Infectious Prophylaxis in MDS Patients Treated with Azacitidine (AZA): A Prospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only